News & Events - Momentis Surgical™ - Robotics Surgery Made Natural Anovo™ Surgical System

News & Eventsmonimono2021-03-01T20:57:03+00:00

News: Memic Innovative Surgery Announces its Rebrand to Momentis Surgical™ to Reflect Corporate Transformation

Memic Innovative Surgery Ltd. (Memic) today announced that it has rebranded to become Momentis Surgical™ and has changed the name of its proprietary technology from Hominis® Surgical System to Anovo™ Surgical System.

News: Memic Announces Completion of First Patient Cases Using Hominis® Surgical System in Laparoscopic-Assisted Transvaginal Benign Gynecological Procedures

Patient procedures performed at HCA Florida Kendall Hospital and The Women’s Hospital at Jackson Memorial with first and only FDA-authorized surgical robot with humanoid-shaped arms

News: Memic Announces Multiple Upcoming Presentations of Hominis® Surgical System at Society of Robotic and Digital Surgery 2022 Annual Meeting

Memic Innovative Surgery Ltd. (Memic), a medical device company dedicated to transforming surgery with its proprietary surgical robotic technology, today announced that multiple abstracts detailing clinical data related to the Hominis® Surgical System for robotic-assisted transvaginal hysterectomy were accepted for presentation at the Society of Robotic and Digital Surgery (SRS) 2022 Annual Meeting

News: HCA Florida Kendall Hospital Physician Performs First Surgery of its Kind in the U.S., Thanks to New Cutting-Edge Technology

Doctors at HCA Florida Kendall Hospital performed the first of its kind minimally invasive hysterectomy in the U.S., thanks to new technology available at only a few hospitals in the world.

News: Memic Innovative Surgery Named to Fast Company’s Annual List of World’s 50 Most Innovative Companies for 2022

Momentis included in the list along with companies such as Canva, Microsoft, SpaceX

News: VirtaMed and MemicAnnounce Partnership for Development of New Robotics Virtual Reality Training Simulator

New program to support surgeon training for FDA-authorized Anovo™ Surgical System, the first-ever surgical robot with humanoid-shaped arms

News: Memic Announces Adoption of Hominis® Surgical System at Three Leading U.S. Hospitals in Q4 2021

HCA Florida Healthcare's Kendall Regional Medical Center, AdventHealth Celebration and The Women's Hospital at Jackson Memorial now offer first-ever surgical robot with humanoid-shaped arms for use in transvaginal gynecological procedures

News: BioFlorida Celebrates Life Sciences Innovation in the State

The Deal of The Year is Memic's $96 million Series D financing to support the commercialization of the company's innovative Anovo™ Surgical System in the U.S and was awarded to CEO Dvir Cohen

News: Memic Strengthens Management Team with Key Appointments

Senior leadership in sales, R&D and operations including new chief commercial officer positions Momentis for growth and success as company launches Anovo™ Surgical System surgical robot

News: Memic Innovative Surgery to Demonstrate Use of Hominis Surgical System at AAGL 2021

Company to showcase first and only FDA-authorized surgical robot that features miniature humanoid-shaped arms and host in-booth surgeons to discuss their experiences with Hominis

News: Memic Announces Robert L. Ryan and Sandra Morgan to Join Board of Directors Upon Closing of Business Combination with MedTech Acquisition Corporation

Industry veterans with leadership experience at global companies including Medtronic and HCA will support Memic's global expansion and commercialization strategic planning.

News: Memic Innovative Surgery Ltd. and MedTech Acquisition Corporation Announce Proposed Business Combination

Momentis Surgical’s™ Anovo™ Surgical System platform is the first and only FDA-authorized surgical robot that features miniature humanoid-shaped arms, with shoulder, elbow, and wrist joints, providing human level dexterity and 360-degree articulation

News: Memic Innovative Surgery Raises $96 Million

Funding will support commercialization of the Anovo™ Surgical System robotic-assisted surgical platform in the U.S. and potentially in other countries around the world as the company also plans to expand marketing and sales efforts outside the U.S.

News: Memic Receives FDA De Novo Marketing Authorization for First-Ever Surgical Robotic System with Humanoid-shaped Robotic Arms

Anovo™ Surgical System robot-assisted surgical platform now available for use in transvaginal gynecologic procedures including benign hysterectomy

News: Clinical experience with a robotic assisted system for transvaginal gynecologic surgery

Presentation given at the American Urogynecologic Society Meeting

News: Memic Performs First Israel Case in Transvaginal Hysterectomy Study

The procedure was performed by Prof. Lior Lowenstein of Haifa’s Rambam Healthcare Campus

News: Hominis Used in First Transvaginal Robotic Hysterectomy in Belgium

In a first-of-its-kind procedure in Belgium, Dr. Jan Baekelandt of Bonheiden’s Imelda Hospital has performed a transvaginal robotic-assisted hysterectomy using Momentis Surgical’s™ technology

News: Memic Initiates Clinical Trial of Innovative Transvaginal Robotic Hysterectomy

a two-center clinical trial to investigate the use of the company’s cutting-edge Anovo™ Surgical System robotic platform in the performance of transvaginal hysterectomy

News: Memic Appoints Dr. Maurice Ferré Chairman of BOD Following $10M Financing Round

Signing on as a private investor, Mr. Ferré has over 20 years of experience in the medical device industry

News: Memic’s Hominis® Surgical System robotic-assisted surgical platform granted patent for both method and device for hysterectomy

In a major leap for the company’s intellectual property, Momentis has been granted a US patent for its Hominis® robotic-assisted surgical platform, securing both the device itself and its unique method for transvaginal hysterectomy

Indications for use: The Anovo™ Surgical System is an endoscopic instrument control system that is intended to assist in the accurate control of the Anovo™ Arms during single site, natural orifice laparoscopic-assisted transvaginal benign surgical procedures listed below. The Anovo™ Surgical System is indicated for use in adult patients. It is intended to be used by trained physicians in an operating room environment. The representative uses of the Anovo™ Surgical System are indicated for the following benign procedures: Total Benign Hysterectomy with Salpingo-Oophorectomy • Total Benign Hysterectomy with Salpingectomy • Total Benign Hysterectomy • Salpingectomy • Oophorectomy • Adnexectomy • Ovarian cyst removal. Caution: The safety and effectiveness of the Anovo™ Surgical System was established only for the representative uses mentioned in the Indications for Use. The demonstration of safety and effectiveness for the representative specific procedures did not include evaluation of outcomes related to the treatment of cancer (overall survival, disease-free survival, local recurrence) or treatment of the patient’s underlying is ease/condition. Device usage in all surgical procedures should be guided by the clinical judgment of an adequately trained surgeon. The prescription-use symbol or “Caution: Federal law restricts this device to sale by or on the order of a physician.” For safety information, including risks, indications, and specific warnings and cautions related to the Anovo™ System please refer to the Anovo™ Surgical System Instructions for Use provided with your Anovo™ Surgical System.